have reported a very valuable study comparing the prognostic utility of exercise testing and cardiac catheterization in post-myocardial infarction patients. Certain aspects of their data analysis require further discussion.
results. The exercise test in the study of De Feyter et al. was an excellent screening examination, identifying 22 of 23 patients at risk for recurrent infarction or death. If the results had been applied to a population of patients receiving usual care in the community, 99 false-positive responders might have been subjected to unnecessary medical therapy or cardiac catheterization, both of which have acceptably low risks. The single false-negative responder might have been denied further necessary diagnostic testing and therapy. Whereas cardiac catheterization is often used to further stratify highrisk patients after exercise testing, such a strategy is not supported by this study. The sensitivity of the catheterization was inadequate, identifying only 15 of 23 patients at risk for reinfarction or death; eight falsenegative patients would have been denied potentially life-saving therapy. The specificity of catheterization, while better than that of exercise testing, decreased the number of false-positive responders only from 99 to 31. While a false-positive exercise test may result in unnecessary catheterization or medical therapy, a false-positive catheterization may, in a large proportion of patients, result in unnecessary revascularization surgery. Indeed, if a decision for surgical intervention had been based on catheterization studies, as is often the case in clinical practice, twice as many false-positive patients would have undergone surgery as truepositive patients: 31 and 15, respectively.
The authors' data do not support their contention that "angiographic variables are better predictors for cardiac death and recurrent myocardial infarction than exercise test variables." 
